A comprehensive, 40+ slide analysis offering clear, practical guidance to help pharmaceutical teams understand generic entry, pricing, reimbursement pathways, and LOE implications across Canadian public and private payers.

Overview

Loss of Exclusivity (LOE) remains one of the most significant inflection points for any brand — and in Canada, evolving generic pricing frameworks, jurisdictional requirements, and payer expectations make planning increasingly complex. 

MORSE’s Canadian Generic Landscape Report 2025 provides a grounded, real-world view of how generics are considered, priced, reimbursed, and adopted across Canada. Designed for teams responsible for LOE planning, lifecycle management, forecasting, and competitive strategy, this report helps you anticipate the impact of generic entry on both brand and market dynamics. 

Built from MORSE Consulting’s experience across public and private payers, this 40+ slide report equips your team with the insights needed to prepare confidently — whether it’s your brand approaching LOE or a competitor going generic. 

What This Report Provides

A practical, system-minded perspective on: 

  1. Generic Evaluation & Reimbursement Pathways
  • Overview of how generics are assessed by key Canadian agencies & drug plans 
  • Jurisdictional submission requirements and timing expectations 
  • What drives variation in generic listing patterns 
  1. Generic Pricing Frameworks & Market Implications
  • Breakdown of Canada’s generic pricing framework 
  • How pricing interacts with list prices for brands and generics 
  • Differences across provinces and oncology vs. non-oncology 
  • Real world examples of shifts in reimbursement access with generic entries 
  1. EAP and Uptake Dynamics
  • Provincial rules for no substitution and general transition timelines 
  • Differences in ON’s Exceptional Access Program (EAP) 
  1. Strategic LOE Considerations for Brand Products
  • What happens to brand PLAs after generics enter 
  • Potential alternatives for maintaining some access post-LOE  
  • Approaches to mitigate erosion through lifecycle strategies 
  • The role of line extensions and product variations in LOE planning 

Who This Report Is For 

Designed for pharmaceutical market access teams at the global and Canadian affiliate level, including: 

  • Market Access & Government Affairs 
  • Pricing Strategy 
  • HEOR 
  • Forecasting & Commercial Planning 
  • Lifecycle Management 

 

Why MORSE Consulting 

MORSE is known across the industry for providing: 

  • Credible, experience-informed guidance: Insights grounded in monitoring across public and private payer environments 
  • Deep LOE expertise: A focused team with detailed understanding of Canadian generic evaluation, pricing, and substitution frameworks 
  • System-minded perspective: Analysis that reflects the realities facing payers, manufacturers, and the broader health system 

Included With Your Purchase: 1-Hour Expert Q&A Session 

To support practical application of the report’s insights, each purchase includes a complimentary 1-hour virtual Q&A session with a MORSE LOE/generics expert. 

Use this session to discuss: 

  • LOE timing assumptions and likelihood of generic entry 
  • Provincial evaluation and reimbursement pathways 
  • Interchangeability and substitution timing 
  • Early uptake expectations and payer transition behaviours 
  • Strategic options for maintaining brand access post-LOE 
  • Implications when a competitor genericizes 

This dedicated session ensures your team can translate insights into actionable LOE planning. 

Pricing & Access 

The Canadian Generic Landscape Report 2025 is available for purchase. 

To request a detailed Table of Contents or pricing information fill out the form on this page.

  • Canadian Reimbursement Forecasting Timelines Report
  • Canadian Reimbursement Forecasting Timelines Report 1

For further information, please complete the form below.

This report is only available to pharmaceutical companies to assist with their reimbursement forecasting and planning.


We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

Loss of Exclusivity Report 2025
Learn More
Learn More